the aid library

LIST OPTIONS

Filter

16034

Sort by:

Direction:

Download (97)

View PDF (955)

An Introduction to Screening and Treatment for Cervical Cancer

Medica Aid Films (2021) CC

This film explains the importance of screening, early detection and treatment of cervical cancer. This film is for use in skilled health worker training. Available in English, French, Somali and Swahili

Download (94)

View PDF (401)

Nourishing children: Menus for recovery (1st Edition)

World Vision (2023) CC

A book of rehabilitation menus from 23 countries developed by World Vision staff and the communities they work in, using locally available, low-cost, nutrient-dense ingredients. Many times, you will find included in the recipes neglected underutilised indigenous foods that are contextual to the area... more

Download (253)

View PDF (296)

Community Engagement During Public Health Emergencies Like COVID-19: An Action Framework and Toolkit

Bangladesh Red Crescent Society; BRAC; Government of Bangladesh; UN Children's Fund UNICEF; UN Women; World Health Organization WHO (2023) CC

This handbook offers a simple framework of action for actors in local government, and in particular, health leaders such as Civil Surgeons (CSs) and Upazila Health and Family Planning Officers (UHFPQOs), to take ownership and leadership to combat COVID-19 at each district and upazila respectively, w... more

Download (323)

View PDF (161)

Infection Prevention and Control Standard Operating Procedures For Cholera Treatment Centres and Units in Malawi (April 2023)

Africa Centres for Disease Control and Prevention Africa CDC; African Union; Government of Malawi; Médecins Sans Frontières; UN Children's Fund UNICEF; World Health Organization WHO (2023) CC

Infection prevention and control (IPC) in a CTC/ CTU IPC are all practical measures taken in the healthcare facility to prevent harm caused by infections to patients, health workers and communities. The main goal of IPC in the cholera response is to • To reduce transmission of health care-as... more

Download (247)

View PDF (332)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (178)

View PDF (142)

Protecting maternal, newborn and child health from the impacts of climate change: call for action

World Health Organization WHO (2023) C_WHO

Climate hazards, including extreme heat, are associated with increased risks of developing complications that lead to adverse maternal and perinatal outcomes. These may include multiple causes of maternal and neonatal morbidity and mortality such as gestational diabetes, hyper tensive disorders of p... more

Download (166)

View PDF (125)

A Guide to Inclusive Education 2023
recommended

Jesuit Refugee Service (2023) CC

Refugee children with disabilities experience a reality of exclusion and marginalisation that makes them among the most vulnerable displaced persons in the world. Excluded from participation in social activities and access to school, not only because of their disability, but especially because of so... more

Download (142)

View PDF (193)

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO

This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...2021–2030 to attain the Sustainable Development Goals (SDGs) by 2030. The Lao People’s Democratic Republic experienced substantial economic growth in the 30 years prior to the coronavirus disease (COVID-19) pandemic, contributing to reduced poverty and significant progress toward the SDGs. However, the COVID-19 pandemic brought this development to a halt. It was anticipated that the COVID-19 recovery and the tremendous population growth in recent years would provide opportunities for a shift toward more sustainable and inclusive development in the years ahead. In 2023, however, the contrary was the case. Rural residents, including many ethnic minorities, continued to face marginalization because of limited access to education, health care and economic opportunities. Despite the challenges of COVID-19 and other disease outbreaks, the country has made significant improvements in health. Nonetheless, progress has been uneven and not everyone has benefited from these achievements. In the mountainous region, many people lack access to quality health care because of the unequal distribution of well-trained health-care workers. Preventable deaths due to poor-quality health care for children and newborns, infants and mothers remain a concern, as do communicable diseases such as sexually transmitted infections and tuberculosis. The increasing burden of noncommunicable diseases and the health impact of worsening climate change further heighten the need for strengthened and resilient health systems, which are at risk due to an underfunded health sector and weak economy. This CCS aims to address remaining and future challenges as well as health needs while creating an impact that is sustainable. It identifies three strategic priorities and nine deliverables (Table 1) to support the attainment of the national vision of Health for all by all, as articulated in the 9th Health Sector Development Plan 2021–2025. It contributes to the country’s goals to achieve universal health coverage, graduate from least developed country status by 2026 and attain SDGs by 2030. more

Download (28)

View PDF (16)

Info-Centre

The Children’s Cardiac Foundation of Africa (2022) CC

The Children’s Cardiac Foundation deals with a wide rage of stakeholders from parents of children affected by CHD, to corporates and grant makers. Before contacting us, please read the relevant sections below as your questions may have already been answered.

Download (121)

View PDF (129)

Facilitators’ guide for conducting national and subnational programme reviews for maternal, newborn, child and adolescent health

World Health Organization WHO (2024) C_WHO

Download (856.2 kB) Overview A programme review for maternal, newborn, child and adolescent health (MNCAH) is a process for assessing mid- or end-term country progress in improving the health of women, newborns, children and adolescents. A programme review is conducted at the national or subnation... more

Download (109)

View PDF (90)

Improving the health and wellbeing of children and adolescents:guidance on scheduled child and adolescent well-care visits

World Health Organization WHO (2024) C_WHO

To survive and thrive, children and adolescents need good health, adequate nutrition, security, safety and a supportive clean environment, opportunities for early learning and education, responsive relationships and connectedness, and opportunities for personal autonomy and self-realization. To prom... more

Download (23)

View PDF (14)

Sa Heart Association Health Professionals Resources

SA Heart Association (2024) CC

Webinars, PDFs, Videos, papers in different topics e.g. adult congenital heart disease, aortic disease, atherosclerosis etc.

Download (15)

View PDF (15)

Guide for Nurses

India Hypertension Control Initiative (2022) CC

This guide can be used to train nurses in the field to succeed in their role in the hypertension program. It teaches how to screen patients correctly, register and follow-up with patients, retrieve defaulters, record patient visits, and to report data.

Download (138)

View PDF (119)

Marketing of breast-milk substitutes: national implementation of the International Code, status report 2024
recommended

World Health Organisation (WHO) (2024) C_WHO

This report provides updated information on the status of implementation of the International Code of Marketing of Breast-milk Substitutes (BMS) and subsequent relevant World Health Assembly (WHA) resolutions (collectively referred to as “the Code”) in countries. It presents the legal status of ... more

Download (77)

View PDF (74)

Maternal and neonatal tetanus elimination in Latin America and the Caribbean. Field Guide

Pan American Health Organization (PAHO) (2024) C_WHO

Neonatal tetanus (NT), a severe newborn illness from the toxigenic strains of Clostridium tetani, persists in middle- and low-income countries due to non-sterile childbirth practices. Unlike smallpox and polio, tetanus cannot be eradicated: Clostridium tetani spores exist in the environment, and ani... more

Download (95)

View PDF (92)

Monitoring children’s development in Europe and central Asia with a focus on primary health care: directions for policy and practice

World Health Organisation (WHO) (2024) C_WHO

This publication aims to provide an overview of the state of developmental monitoring in selected countries across the Europe and Central Asia region (ECAR), to document the existing evidencebased approaches and models for developmental monitoring and to identify the key considerations necessary to ... more

Download (65)

View PDF (51)

Access to sexual and reproductive health services in the Region of the Americas

Pan American Health Organization (PAHO) (2024) C_WHO

This brief presents the guidelines and agreements in the information document Status of access to sexual and reproductive health services, prepared by the Pan American Health Organization (PAHO) at the request of its Member States at the 30th Pan American Sanitary Conference. It was presented and un... more